Emcure Pharmaceuticals Overview
- Year Founded
-
1981
- Status
-
Public
- Employees
-
9,597
- Stock Symbol
-
544210
- Investments
-
13
- Share Price
-
$25.04
- (As of Friday Closing)
Emcure Pharmaceuticals General Information
Description
Emcure Pharmaceuticals Ltd is an Indian pharmaceutical company engaged in developing, manufacturing, and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals, including solids, liquid orals, and dry syrup/suspensions; injectables such as vials and pre-filled syringes; and forms such as lyophilized & liquid, and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives categories. It has a single reportable operating segment, viz. Pharmaceuticals. Geographically, the company derives the maximum revenue from India, and the rest from Europe, North America, and other regions.
Contact Information
Website
www.emcure.comCorporate Office
- Plot Number P-1 and P-2, IT-BT Park, Phase II
- M.I.D.C.,Hinjawadi
- Pune, 411057
- India
Corporate Office
- Plot Number P-1 and P-2, IT-BT Park, Phase II
- M.I.D.C.,Hinjawadi
- Pune, 411057
- India
Emcure Pharmaceuticals Stock Performance
As of 20-Nov-2026, Emcure Pharmaceuticals’s stock price is $25.04. Its current market cap is $4.75B with 190M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.04 | $25.10 | $15.03 - $25.69 | $4.75B | 190M | 37.8K | $0.62 |
Emcure Pharmaceuticals Financials Summary
As of 30-Sep-2026, Emcure Pharmaceuticals has a trailing 12-month revenue of $1.1B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 3,986,445 | 3,318,835 | 2,493,681 | |
| Revenue | 1,103,776 | 1,031,632 | 923,430 | 795,062 |
| EBITDA | 223,897 | 206,410 | 175,791 | 147,316 |
| Net Income | 117,936 | 104,609 | 80,576 | 60,177 |
| Total Assets | 1,058,163 | 1,018,783 | 962,449 | 936,064 |
| Total Debt | 182,905 | 161,229 | 119,565 | 279,994 |
Emcure Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Emcure Pharmaceuticals Comparisons
Industry
Financing
Details
Emcure Pharmaceuticals Competitors (67)
One of Emcure Pharmaceuticals’s 67 competitors is Granules India, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Granules India | Corporation | Hyderabad, India | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Dr. Reddy's | Corporation | Hyderabad, India | ||||
| Beximco Pharmaceuticals | Corporation | Dhaka, Bangladesh |
Emcure Pharmaceuticals Patents
Emcure Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026154372-A1 | Semaglutide in-situ gel formulation for parenteral administration | Pending | 16-Jan-2025 | ||
| WO-2026133119-A1 | Topical formulation for controlled delivery of active ingredient | Pending | 20-Dec-2024 | ||
| WO-2026083220-A1 | Cidofovir lipid based topical gel formulation | Pending | 18-Oct-2024 | ||
| WO-2026033305-A1 | Fused bicyclic heterocyclic derivatives as hdac inhibitors | Pending | 06-Aug-2024 | ||
| EP-4812481-A1 | Deuterated dydrogesterone | Pending | 22-Nov-2023 | A61P15/00 |
Emcure Pharmaceuticals Signals
Emcure Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Emcure Pharmaceuticals Investments & Acquisitions (13)
Emcure Pharmaceuticals’s most recent deal was a Merger/Acquisition with Gennova for . The deal was made on 17-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gennova | 17-Jul-2026 | Merger/Acquisition | Drug Discovery | ||
| Cutimed | 01-Apr-2026 | Merger/Acquisition | Personal Products | ||
| Zuventus Healthcare | 03-Oct-2025 | Secondary Transaction - Private | Pharmaceuticals | ||
| Sunsure Solarpark Twelve | 25-Jul-2024 | Secondary Transaction - Private | Energy Production | ||
| Zuventus Healthcare | 07-Feb-2024 | Merger/Acquisition | Pharmaceuticals |
Emcure Pharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
45.28 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Emcure Pharmaceuticals Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cutimed | Boucherville, Canada | 2011 | |
| Bharadwaj Pharma | Hamburg, Germany | 2009 | |
| Zuventus Healthcare | Pune, India | 2002 | |
| Gennova | Pune, India | 2001 | |
| Tillomed Laboratories | Luton, United Kingdom | 1990 |
Emcure Pharmaceuticals FAQs
-
When was Emcure Pharmaceuticals founded?
Emcure Pharmaceuticals was founded in 1981.
-
Where is Emcure Pharmaceuticals headquartered?
Emcure Pharmaceuticals is headquartered in Pune, India.
-
What is the size of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has 9,597 total employees.
-
What industry is Emcure Pharmaceuticals in?
Emcure Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Emcure Pharmaceuticals a private or public company?
Emcure Pharmaceuticals is a Public company.
-
What is Emcure Pharmaceuticals’s stock symbol?
The ticker symbol for Emcure Pharmaceuticals is 544210.
-
What is the current stock price of Emcure Pharmaceuticals?
As of 20-Nov-2026 the stock price of Emcure Pharmaceuticals is $25.04.
-
What is the current market cap of Emcure Pharmaceuticals?
The current market capitalization of Emcure Pharmaceuticals is $4.75B.
-
What is Emcure Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Emcure Pharmaceuticals is $1.1B.
-
Who are Emcure Pharmaceuticals’s competitors?
Granules India, Amneal Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's, and Beximco Pharmaceuticals are some of the 67 competitors of Emcure Pharmaceuticals.
-
What is Emcure Pharmaceuticals’s annual earnings per share (EPS)?
Emcure Pharmaceuticals’s EPS for 12 months was $0.62.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process